Quanta
Burbank, US · Founded 2016 · Nevada corporation · 1 known investors
Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities. The device targets dialysis patients and providers with a self-care-capable design intended to lower operational costs while delivering clinical performance.
Founders & leadership
ER
ERIC RICENamed on SEC filing
JD
JEFFREY DOIRONNamed on SEC filing
BG
BLAKE GILETTENamed on SEC filing
KW
KIRK WESTWOODNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2019
▶$500KraisedDec 2019 · 3 investors · OtherRule 506(b)
▶$500KraisedDec 2019 · 3 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- ERIC RICEExecutive Officer
- JEFFREY DOIRONExecutive Officer
- BLAKE GILETTEExecutive Officer
- KIRK WESTWOODExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Nov 2019
- Incorporated
- Corporation, Nevada, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapAlibaba (Link14 shared keywordsAlibaba.com operates a global B2B e-commerce marketplace that connects buyers with suppliers and manufacturers for wholesale products across multiple industries. The platform provides trade services, logistics support, payment protection, and AI-powered sourcing tools for businesses.
Quanta Therapeutics13 shared keywordsQuanta is a biotech company developing orally bioavailable, CNS-penetrant small-molecule KRAS inhibitors targeting RAS-driven cancers such as pancreatic, colorectal, lung, and endometrial cancers. Its pipeline includes clinical and preclinical candidates aimed at KRAS mutations (including G12D and G12V) beyond those addressed by approved G12C inhibitors, alongside a RAS-partner discovery program using conformation-sensitive assays.
Kidney12 shared keywordsThe National Kidney Foundation works to eliminate preventable kidney disease, accelerate innovation in patient care, and address structural inequities in kidney treatment and transplantation services. The organization serves patients with kidney disease and at-risk communities.
Companies competing with Quanta for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Quanta do?
- Quanta develops the Quanta Dialysis System, a compact, modular hemodialysis machine designed for flexible kidney care in acute and chronic facilities. The device targets dialysis patients and providers with a self-care-capable design intended to lower operational costs while delivering clinical performance.
- Who are Quanta's investors?
- Quanta's investors include Seroba Life Sciences.
- How much funding has Quanta raised?
- Quanta has disclosed $500K raised across 1 round.
- Where is Quanta headquartered?
- Quanta is headquartered in Burbank, US.